Feedback / Questions
HB-201 - Hookipa Pharma
Keytruda (pembrolizumab) - Merck (MSD)
eseba-vec (HB-200) - Hookipa Pharma
http://clinicaltrials.gov/ct2/show/NCT04180215
Sep 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next